Transform messy spreadsheets, remove errors, and refresh tables automatically without writing a single formula.

Chef John “Chappy” Chapman opens Coastal Kitchen in Long Beach decades after Katrina. Coastal Kitchen menu centers on seafood, steak and cocktails, opened in December. Chapman returns to Mississippi ...

WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval of new drugs, the latest change from Trump administration ...

Microsoft Sentinel data lake tier now supports Advanced Hunting Tables ingestion for lower-cost security storage. Defender telemetry flows directly into Sentinel data lake, enabling extended retention ...

Add Yahoo as a preferred source to see more of our stories on Google. Megyn Kelly skewered MS NOW — which unknowingly used what the channel admitted was an “AI-enhanced” picture of Alex Pretti — with ...

Ms. Rachel is apologizing for liking a controversial comment on social media. The wildly popular children's entertainer, whose legal name is Rachel Accurso, drew criticism after screenshots circulated ...

Abstract: Multibeam satellite system (MSS) plays an increasingly important role in the future communication system because of the ability to provide seamless information services. However, multibeam ...

For the first time, UCL researchers have used AI to identify two biologically distinct forms of MS, supporting the potential for more personalised care and improved treatment decisions for patients ...

NICE recommends natalizumab, including a lower-cost biosimilar, as a new MS treatment for adults with highly active relapsing-remitting multiple sclerosis, expanding options for thousands of patients ...

Russell has a PhD in the history of medicine, violence, and colonialism. His research has explored topics including ethics, science governance, and medical involvement in violent contexts. Russell has ...

Annual out-of-pocket costs for multiple sclerosis (MS) care in the US increased by 125% from 2002 to 2021, primarily driven by newer disease-modifying therapies (DMTs), a new study showed. Researchers ...

Sanofi is scrapping plans to get one of its more advanced experimental medicines approved for a certain kind of multiple sclerosis, following negative results from a clinical trial disclosed Monday.